Bone disease in cystic fibrosis: What's new?

Joint Bone Spine

Volumn 78, Issue 5, 2011, Pages 445-450

  Javier, Rose Marie ^a   Jacquot, Jacky ^b  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b INSERM   (France)

Author keywords

Bone mineral density; Cystic fibrosis; Fractures; Osteoporosis

Indexed keywords

ALENDRONIC ACID; CALCIUM; COLECALCIFEROL; ETIDRONIC ACID; GLUCOCORTICOID; GROWTH HORMONE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 6; OSTEOCALCIN; PAMIDRONIC ACID; PARATHYROID HORMONE[1-34]; TETRACYCLINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN K GROUP; ZOLEDRONIC ACID;

ABSORPTIOMETRY; BODY WEIGHT; BONE DENSITY; BONE DISEASE; BONE TISSUE; BONE TURNOVER; CALCIUM INTAKE; CERVICAL SPINE RADIOGRAPHY; CYSTIC FIBROSIS; DELAYED PUBERTY; DIET; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLOW UP; FRACTURE; GENE MUTATION; HIGH CALORIE HIGH PROTEIN DIET; HORMONAL THERAPY; HUMAN; HYPOGONADISM; IMMUNOSUPPRESSIVE TREATMENT; ISOTOPE LABELING; MALABSORPTION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PANCREAS EXOCRINE INSUFFICIENCY; PATHOPHYSIOLOGY; PHOTOTHERAPY; PHYSICAL ACTIVITY; RECURRENT INFECTION; RISK ASSESSMENT; SHORT SURVEY; TREATMENT INDICATION; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT BEARING;

BONE DENSITY; CYSTIC FIBROSIS; FRACTURES, BONE; HUMANS; OSTEOPOROSIS; RISK FACTORS;

EID: 80053441931     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.11.015     Document Type: Short Survey

References (60)

1. Buzzetti R., Salvatore D., Baldo E., et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009, 8:229-237.
2. Riordan J.R. CFTR function and prospects for therapy. Annu Rev Biochem 2008, 77:701-726.
3. Becq F. Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date. Drugs 2010, 70:241-259.
4. Harmon G.S., Dumlao D.S., Ng D.T., et al. Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice. Nat Med 2010, 16:313-318.
5. Boucher R.C. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 2007, 58:157-170.
6. Jouret F., Devuyst O. CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis. Pflugers Arch 2009, 457:1227-1236.
7. Chanson M. Cystic fibrosis, fatty acid imbalance, ceramide, and lipid rafts. Arch Pediatr 2009, 16:543-545. [Article in French].
8. Borot F., Vieu D.L., Faure G., et al. Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells. PLoS One 2009, 4:e7116.
9. Vij N., Mazur S., Zeitlin P.L. CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS One 2009, 4:e4664.
10. Jacquot J., Tabary O., Clement A. Hyperinflammation in airways of cystic fibrosis patients: what's new?. Expert Rev Mol Diagn 2008, 8:359-363.
11. Aris R.M., Merkel P.A., Bachrach L.K., et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005, 90:1888-1896.
12. Aris R.M., Renner J.B., Winders A.D., et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998, 128:186-193.
13. Shane E., Silverberg S.J., Donovan D., et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996, 101:262-269.
14. Latzin P., Griese M., Hermanns V., et al. Sternal fracture with fatal outcome in cystic fibrosis. Thorax 2005, 60:616.
15. Paccou J., Zeboulon N., Combescure C., et al. The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif Tissue Int 2010, 86:1-7.
16. Elkin S.L., Fairney A., Burnett S., et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 2001, 12:366-372.
17. King S.J., Topliss D.J., Kotsimbos T., et al. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor. Eur Respir J 2005, 25:54-61.
18. Stephenson A., Jamal S., Dowdell T., et al. Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density. Chest 2006, 130:539-544.
19. Wolfenden L.L., Judd S.E., Shah R., et al. D and bone health in adults with cystic fibrosis. Clin Endocrinol (Oxf) 2008, 69:374-381.
20. Rovner A.J., Zemel B.S., Leonard M.B., et al. Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents. J Pediatr 2005, 147:327-331.
21. Grey A.B., Ames R.W., Matthews R.D., et al. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 1993, 48:589-593.
22. Buntain H.M., Greer R.M., Schluter P.J., et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 2004, 59:149-155.
23. Sood M., Hambleton G., Super M., et al. Bone status in cystic fibrosis. Arch Dis Child 2001, 84:516-520.
24. Henderson R.C., Madsen C.D. Bone mineral content and body composition in children and young adults with cystic fibrosis. Pediatr Pulmonol 1999, 27:80-84.
25. Conway S.P., Oldroyd B., Brownlee K.G., et al. A cross-sectional study of bone mineral density in children and adolescents attending a Cystic Fibrosis Centre. J Cyst Fibros 2008, 7:469-476.
26. Ionescu A.A., Nixon L.S., Evans W.D., et al. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000, 162:789-794.
27. Rossini M., Del Marco A., Dal Santo F., et al. Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone 2004, 35:771-776.
28. Frangolias D.D., Pare P.D., Kendler D.L., et al. Role of exercise and nutrition status on bone mineral density in cystic fibrosis. J Cyst Fibros 2003, 2:163-170.
29. Ujhelyi R., Treszl A., Vasarhelyi B., et al. Bone mineral density and bone acquisition in children and young adults with cystic fibrosis: a follow-up study. J Pediatr Gastroenterol Nutr 2004, 38:401-406.
30. Aris R.M., Neuringer I.P., Weiner M.A., et al. Severe osteoporosis before and after lung transplantation. Chest 1996, 109:1176-1183.
31. Lewiecki E.M., Gordon C.M., Baim S., et al. International society for clinical densitometry 2007 adult and pediatric official positions. Bone 2008, 43:1115-1121.
32. Sermet-Gaudelus I., Souberbielle J.C., Ruiz J.C., et al. Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Care Med 2007, 175:951-957.
33. Grey V., Atkinson S., Drury D., et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 2008, 122:1014-1020.
34. Bianchi M.L., Romano G., Saraifoger S., et al. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 2006, 21:388-396.
35. Aris R.M., Lester G.E., Dingman S., et al. Altered calcium homeostasis in adults with cystic fibrosis. Osteoporos Int 1999, 10:102-108.
36. Aris R.M., Ontjes D.A., Buell H.E., et al. Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 2002, 13:151-157.
37. Greer R.M., Buntain H.M., Potter J.M., et al. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Osteoporos Int 2003, 14:404-411.
38. Shead E.F., Haworth C.S., Barker H., et al. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J Cyst Fibros 2010, 9:93-98.
39. Bell S.C., Bowerman A.M., Nixon L.E., et al. Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. Eur J Clin Invest 2000, 30:553-559.
40. Conway S.P. Impact of lung inflammation on bone metabolism in adolescents with cystic fibrosis. Paediatr Respir Rev 2001, 2:324-331.
41. Haworth C.S., Webb A.K., Egan J.J., et al. Bone histomorphometry in adult patients with cystic fibrosis. Chest 2000, 118:434-439.
42. Elkin S.L., Vedi S., Bord S., et al. Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am J Respir Crit Care Med 2002, 166:1470-1474.
43. Gordon C.M., Binello E., LeBoff M.S., et al. Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis. Osteoporos Int 2006, 17:783-790.
44. Nicolaidou P., Stavrinadis I., Loukou I., et al. The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur J Pediatr 2006, 165:540-545.
45. Hall W.B., Sparks A.A., Aris R.M. Vitamin d deficiency in cystic fibrosis. Int J Endocrinol 2010, 2010:218691. [Epub 2010 Jan 28].
46. Stephenson A., Brotherwood M., Robert R., et al. Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr 2007, 85:1307-1311.
47. Boyle M.P., Noschese M.L., Watts S.L., et al. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med 2005, 172:212-217.
48. Rovner A.J., Stallings V.A., Schall J.I., et al. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 2007, 86:1694-1699.
49. Shead E.F., Haworth C.S., Gunn E., et al. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am J Respir Crit Care Med 2006, 174:306-311.
50. Dif F., Marty C., Baudoin C., et al. Severe osteopenia in CFTR-null mice. Bone 2004, 35:595-603.
51. Haston C.K., Li W., Li A., et al. Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice. Am J Respir Crit Care Med 2008, 177:309-315.
52. Divangahi M., Balghi H., Danialou G., et al. Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet 2009, 5:e1000586. [Epub 2009 Jul 31].
53. Pashuck T.D., Franz S.E., Altman M.K., et al. Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation. Pediatr Res 2009, 65:311-316.
54. Shead E.F., Haworth C.S., Condliffe A.M., et al. Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax 2007, 62:650-651.
55. Bronckers A., Kalogeraki L., Jorna H.J., et al. The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells. Bone 2010, 46:1188-1196.
56. Le Heron L., Guillaume C., Velard F., et al. Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E(2) in human bone. J Cyst Fibros 2010, 9:69-72.
57. Hind K., Truscott J.G., Conway S.P. Exercise during childhood and adolescence: a prophylaxis against cystic fibrosis-related low bone mineral density? Exercise for bone health in children with cystic fibrosis. J Cyst Fibros 2008, 7:270-276.
58. Khazai N.B., Judd S.E., Jeng L., et al. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab 2009, 94:2037-2043.
59. Conwell L.S., Chang A.B. Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database Syst Rev 2009, CD002010.
60. Hardin D.S., Ahn C., Prestidge C., et al. Growth hormone improves bone mineral content in children with cystic fibrosis. J Pediatr Endocrinol Metab 2005, 18:589-595.